No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 4,603 | 4,771 | 5,453 | 5,584 | 5,916 | 6,125 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 721 | 728 | 1,027 | 1,007 | 1,079 | 1,308 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Wolters Kluwer N.V. is an international enterprise delivering specialized professional information, software solutions, and services across its home country, the Netherlands, the wider European continent, North America (including the United States and Canada), and the Asia Pacific region. Its operations are structured into four key divisions: Health; Tax & Accounting; Governance, Risk & Compliance; and Legal & Regulatory. The Health segment provides advanced clinical technology and data-backed solutions, empowering healthcare professionals to make informed decisions and achieve superior patient outcomes. Its offerings cater to a wide range of clients, including hospitals, clinics, various healthcare providers, individual medical practitioners and students, educational institutions like nursing and medical schools, libraries, retail pharmacies, insurance payers, and organizations within the life sciences sector. Through its Tax & Accounting segment, the company develops tools that enhance productivity, aid in managing evolving regulations, and secure improved results for tax, accounting, and auditing specialists. These solutions serve accounting firms, corporate finance teams, tax and audit departments, government bodies, libraries, and academic institutions. The Governance, Risk & Compliance division delivers technology-driven services and products focused on legal entity compliance, legal operations oversight, adherence to banking product regulations, and comprehensive regulatory reporting. Its clientele includes legal, compliance, and risk management experts within corporations, small enterprises, law firms, insurance providers, banks, alternative lenders, credit unions, leasing corporations, and securities firms. Finally, the Legal & Regulatory segment furnishes evidence-based data, practical insights, and seamless workflow tools, assisting clients in making optimal choices and simplifying compliance procedures. This segment empowers legal and compliance specialists, operational risk managers, and environmental, health, and safety (EHS) managers to boost their efficiency and output, reduce risks, and confidently resolve intricate challenges across law firms, corporate entities, universities, and government agencies. Established in 1836, Wolters Kluwer N.V. maintains its headquarters in Alphen aan den Rijn, the Netherlands.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Wolters Kluwer N.V. is an international enterprise delivering specialized professional information, software solutions, and services across its home country, the Netherlands, the wider European continent, North America (including the United States and Canada), and the Asia Pacific region. Its operations are structured into four key divisions: Health; Tax & Accounting; Governance, Risk & Compliance; and Legal & Regulatory. The Health segment provides advanced clinical technology and data-backed solutions, empowering healthcare professionals to make informed decisions and achieve superior patient outcomes. Its offerings cater to a wide range of clients, including hospitals, clinics, various healthcare providers, individual medical practitioners and students, educational institutions like nursing and medical schools, libraries, retail pharmacies, insurance payers, and organizations within the life sciences sector. Through its Tax & Accounting segment, the company develops tools that enhance productivity, aid in managing evolving regulations, and secure improved results for tax, accounting, and auditing specialists. These solutions serve accounting firms, corporate finance teams, tax and audit departments, government bodies, libraries, and academic institutions. The Governance, Risk & Compliance division delivers technology-driven services and products focused on legal entity compliance, legal operations oversight, adherence to banking product regulations, and comprehensive regulatory reporting. Its clientele includes legal, compliance, and risk management experts within corporations, small enterprises, law firms, insurance providers, banks, alternative lenders, credit unions, leasing corporations, and securities firms. Finally, the Legal & Regulatory segment furnishes evidence-based data, practical insights, and seamless workflow tools, assisting clients in making optimal choices and simplifying compliance procedures. This segment empowers legal and compliance specialists, operational risk managers, and environmental, health, and safety (EHS) managers to boost their efficiency and output, reduce risks, and confidently resolve intricate challenges across law firms, corporate entities, universities, and government agencies. Established in 1836, Wolters Kluwer N.V. maintains its headquarters in Alphen aan den Rijn, the Netherlands.